健友股份：丙泊酚乳状注射液获美国FDA批准

Core Viewpoint - The company, Jianyou Co., Ltd. (603707), has received ANDA approval from the U.S. FDA for its propofol emulsion injection products, which is expected to positively impact its operational performance [1] Group 1: Product Approval - The U.S. FDA has issued ANDA approval for propofol emulsion injection in three dosages: 200mg/20mL, 500mg/50mL, and 1000mg/100mL, all at a concentration of 10mg/mL [1] - The newly approved products are set to be launched in the U.S. market soon [1] Group 2: Impact on Company Performance - The approval is anticipated to have a positive effect on the company's business performance [1]